keyboard_arrow_up

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

Summary

GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Indonesia, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts.

Visit Complete Report Here: www.marketresearchreports.biz/analysis-details/countryfocus-healthcare-regulatory-and-reimbursement-landscape-indonesia 



In 2013, Indonesias population stood at 251 million, up from 238 million in 2008. The major factors that contributed to the growth in the population are an increase in net migration and a drop in the death rate. The countrys pharmaceutical market was estimated to have been worth $5 billion in 2013 and is expected to reach $9.9 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 10.2%. In 2010, according to US Commercial Service estimates, the countrys medical device market was worth $573m.

The positive trends in the Indonesian healthcare market can primarily be attributed to - 

- Increasing coverage of healthcare insurance

- Improved access to healthcare facilities

Scope

- Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets: PT Kalbe Farma Tbk, PT Tempo Scan Pacific Tbk, Kimia Farma, PT Darya-Varia Laboratoria Tbk and PT Indofarma Tbk

- An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

- Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditureAn overview of the opportunities for and challenges to growth in the healthcare market

Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/194629 

Reasons to buy

The report will enhance your decision-making capability by allowing you to - 

- Develop business strategies through an understanding of the trends shaping and driving the healthcare market

- Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors

Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis/194629 

- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership

- Identify, understand and capitalize on the opportunities and challenges in the healthcare market 

Contact US:    

Office: United States

State Tower

90 State Street, Suite 700

Albany, NY 12207

United States

Toll Free: 866-997-4948

Tel: +1-518-618-1030

E: sales@marketresearchreports.biz